HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes

Jean-Sébastien Hulot; Marine Livrozet

doi:10.1016/j.jacc.2020.11.051

HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes

J Am Coll Cardiol. 2021 Feb 2;77(4):420-422. doi: 10.1016/j.jacc.2020.11.051.

Authors

Jean-Sébastien Hulot¹, Marine Livrozet²

Affiliations

¹ Université de Paris, INSERM, PARCC, Paris, France; CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France. Electronic address: jean-sebastien.hulot@aphp.fr.
² Université de Paris, INSERM, PARCC, Paris, France; CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.

PMID: 33509398
DOI: 10.1016/j.jacc.2020.11.051

No abstract available

Keywords: calcium cycling/excitation-contraction coupling; diabetes; heart failure with preserved ejection fraction; pathophysiology; remodeling; transverse tubules; wall stress.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus*
Heart Failure*
Heart Ventricles
Humans
Myocytes, Cardiac
Stroke Volume